Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,039 | 39,260 | 42,849 | 43,049 | 43,269 |
| Marketable Securities | 35,337 | 9,998 | 9,868 | 24,688 | 40,157 |
| Receivables | 7,790 | 8,947 | 8,305 | 17,377 | 9,927 |
| Other current assets | 0 | 0 | 0 | 0 | 41,999 |
| TOTAL | $99,442 | $60,891 | $62,890 | $86,938 | $137,013 |
| Non-Current Assets | |||||
| PPE Net | 607 | 678 | 695 | 736 | 642 |
| Investments And Advances | 6,105 | 0 | 0 | 0 | 0 |
| Intangibles | 75,309 | 70,855 | 72,400 | 73,928 | 0 |
| Other Non-Current Assets | 10,088 | 11,984 | 15,298 | 10,725 | 1,327 |
| TOTAL | $92,109 | $83,517 | $88,393 | $85,389 | $1,969 |
| Total Assets | $191,551 | $144,408 | $151,283 | $172,327 | $138,982 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 37,700 | N/A |
| Accounts payable and accrued liabilities | 24,464 | 20,452 | 22,785 | 28,403 | 13,080 |
| Other current liabilities | 9,477 | 9,401 | 6,541 | 7,074 | 8,201 |
| TOTAL | $34,481 | $30,449 | $29,909 | $73,720 | $21,714 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,904 | 58,328 | 42,998 | 5,066 | 43,874 |
| Other Non-Current Liabilities | 28,396 | 23,153 | 29,558 | 31,677 | 5,924 |
| TOTAL | $87,300 | $81,481 | $72,556 | $36,743 | $49,798 |
| Total Liabilities | $121,781 | $111,930 | $102,465 | $110,463 | $71,512 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,376 | 52,618 | 41,854 | 43,426 | 36,218 |
| Common Shares | 5 | 4 | 4 | 4 | 3 |
| Retained earnings | -469,550 | -436,325 | -416,400 | -399,778 | -339,468 |
| Other shareholders' equity | -98 | 438 | 158 | -26 | -203 |
| TOTAL | $69,770 | $32,478 | $48,818 | $61,864 | $67,470 |
| Total Liabilities And Equity | $191,551 | $144,408 | $151,283 | $172,327 | $138,982 |